acute monocytic leukemia (MONDO_0007896, a Monarch Disease Ontology entry) can be described as follows. Acute monoblastic leukemia (AML-M5), is one of the most common subtypes of acute myeloid leukemia (AML) that is either comprised of more than 80% of monoblasts (AML-M5a) or 30-80% monoblasts with (pro)monocytic differentiation (AML-M5b). AML-M5 presents with asthenia, pallor, fever, and dizziness. Specific features of AML-M5 include hyperleukocytosis, propensity for extramedullary infiltrates, coagulation abnormalities including disseminated intravascular coagulation and neurological disorders. Leukemia cutis and gingival infiltration can also be seen. A characteristic translocation observed in AML-M5 is t(9;11). Also known as: AML M5, acute monoblastic leukaemia and acute monocytic leukaemia, acute monoblastic leukemia and acute monocytic leukemia, acute monocytic leukaemia (FAB M5B), acute monocytic leukaemia (FAB M5b), acute monocytic leukaemia without mention of remission, acute monocytic leukemia (FAB M5B), acute monocytic leukemia (FAB M5b).